AI MedTech company Weisen announced on the 22nd that it signed a memorandum of understanding (MOU) on the 21st with Ewha Womans University College of Medicine to promote exchange and cooperation in the fields of medical healthcare industry and medical education, as well as to foster talent.


Dean Ha Eun-hee of Ewha Womans University College of Medicine and CEO Kim Kyung-nam of Weisen are holding the agreement and posing for a commemorative photo. <br>[Photo by Weisen]

Dean Ha Eun-hee of Ewha Womans University College of Medicine and CEO Kim Kyung-nam of Weisen are holding the agreement and posing for a commemorative photo.
[Photo by Weisen]

View original image

Through this MOU, the two institutions plan to cooperate in the medical and healthcare fields, explore joint research collaboration with the recently established Ewha Medical AI Center, and actively collaborate from joint research to commercialization to develop medical AI software that can contribute to high-quality medical services. Through this, Weisen intends to build diverse medical evidence to advance products such as Weimed Endo, an AI-based real-time stomach and colon endoscopy video analysis software, and Weimed Cough, a respiratory self-health screening service.



Kim Kyungnam, CEO of Weisen, stated, “This agreement with Ewha Womans University College of Medicine is part of mutual cooperation between companies and medical education institutions for the development of the medical AI industry,” adding, “Since joint research for the advancement of our products with the recently opened Ewha Medical AI Center is already under discussion, we expect to generate synergy in a short period.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing